Genomics is the study of the structure and function of the human genome including genes and their surrounding DNA sequences. The over 3 billion base pairs of the human genome have now been sequenced and approximately 25 000 genes acknowledged. However, only 1% of the entire genome has been assigned to protein coding and decades more work is anticipated to define the functional relevance of noncoding DNA as well as the basis and consequences of sequence variations among individuals. For medical scientists, the focus remains on discovering both disease-causing and disease-susceptibility genes. For pharmaceutical companies, the opportunity to develop molecularly targeted therapy is not going unnoticed. For the practicing physician, the prospect of genomic medicine that incorporates molecular diagnosis and pathogenesis-targeted therapy requires basic understanding of terminology and concepts in molecular biology and the corresponding laboratory tests.
Avise JC.Evolving genomic metaphors: a new look at the language of DNA. Science. 2001;294: 86-87.
2.
Schmid CW, Deininger PL.Sequence organization of the human genome. Cell. 1975;6: 345-358.
3.
Gu Z, Wang H, Nekrutenko A, Li WH.Densities, length proportions, and other distributional features of repetitive sequences in the human genome estimated from 430 megabases of genomic sequence. Gene. 2000;259: 81-88.
4.
Dott PJ, Chuang CR, Saunders GF.Inverted repetitive sequences in the human genome. Biochemistry. 1976; 15: 4120-4125.
5.
Mendel G.Experiments in plant hybridization. Verhandlungen des naturforschenden Vereines in Brunn, Bd. IV fur das Jahr 1865, Abhandlungen, 1865;3-47.
6.
Morgan TH.Sex-limited inheritance in Drosophila. Science. 1910;32: 120-122.
7.
Demerec M.What is a gene?J Heredity. 1933;24: 368-378.
8.
Wieben ED.Primer on medical genomics. Part VII: The evolving concept of the gene. Mayo Clin Proc. 2003; 78: 580-587.
9.
Lander ES, Linton LM, Birren B, et al.Initial sequencing and analysis of the human genome. Nature. 2001; 409: 860-921.
10.
Venter JC, Adams MD, Myers EW, et al.The sequence of the human genome. Science. 2001;291: 1304-1351.
11.
Morel NM, Holland JM, van der Greef J, et al.Primer on medical genomics. Part XIV: Introduction to systems biology—a new approach to understanding disease and treatment. Mayo Clin Proc. 2004;79: 651-658.
12.
Kornberg RD.Chromatin structure: a repeating unit of histones and DNA. Science. 1974;184: 868-871.
13.
Elgin SC.Chromatin structure, DNA structure. Nature. 1982;300: 402-403.
14.
Johns DR.The other human genome: mitochondrial DNA and disease. Nat Med. 1996;2: 1065-1068.
15.
Mattson MP.Mother’s legacy: mitochondrial DNA mutations and Alzheimer’s disease. Trends Neurosci. 1997; 20: 373-375.
16.
Quintana-Murci L, Jamain S, Fellous M.Origin and evolution of mammalian sex chromosomes. C R Acad Sci III. 2001;324: 1-11.
17.
Willard HF.The genomics of long tandem arrays of satellite DNA in the human genome. Genome. 1989; 31: 737-744.
18.
Moyzis RK, Torney DC, Meyne J, et al.The distribution of interspersed repetitive DNA sequences in the human genome. Genomics. 1989;4: 273-289.
19.
Smit AF.The origin of interspersed repeats in the human genome. Curr Opin Genet Dev. 1996;6: 743-748.
20.
Yunis JJ, Roldan L, Yasmineh WG, Lee JC.Staining of satellite DNA in metaphase chromosomes. Nature. 1971; 231: 532-533.
21.
Moxon ER, Wills C.DNA microsatellites: agents of evolution?Sci Am. 1999;280: 94-99.
22.
Wong Z, Wilson V, Patel I, Povey S, Jeffreys AJ.Characterization of a panel of highly variable minisatellites cloned from human DNA. Ann Hum Genet. 1987;51: 269-288.
23.
Efstratiadis A, Kafatos FC, Maniatis T.The primary structure of rabbit β-globin mRNA as determined from cloned DNA. Cell. 1977;10: 571-585.
24.
Lewin B.Units of transcription and translation: the relationship between heterogeneous nuclear RNA and messenger RNA. Cell. 1975;4: 11-20.
25.
Busby S, Ebright RH.Promoter structure, promoter recognition, and transcription activation in prokaryotes. Cell. 1994;79: 743-746.
26.
Saltzman AG, Weinmann R.Promoter specificity and modulation of RNA polymerase II transcription. FASEB J. 1989;3: 1723-1733.
27.
Jeang KT, Khoury G.The mechanistic role of enhancer elements in eukaryotic transcription. Bioessays. 1988; 8: 104-107.
28.
Reinberg D, Orphanides G, Ebright R, Akoulitchev S, Carcamo J, Cho H, et al.The RNA polymerase II general transcription factors: past, present, and future. Cold Spring Harb Symp Quant Biol. 1998;63: 83-103.
29.
Muller CW.Transcription factors: global and detailed views. Curr Opin Struct Biol. 2001;11: 26-32.
30.
Lopez-Rodriguez C, Aramburu J, Rakeman AS, Copeland NG, Gilbert DJ, Thomas S, et al.NF-AT5: the NF-AT family of transcription factors expands in a new direction. Cold Spring Harb Symp Quant Biol. 1999; 64: 517-526.
31.
Jones NC, Rigby PW, Ziff EB.Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes Dev. 1988;2: 267-281.
32.
Sassone-Corsi P, Verma IM.Modulation of c-fos gene transcription by negative and positive cellular factors. Nature. 1987;326: 507-510.
Fong N, Bentley DL.Capping, splicing, and 3’ processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD. Genes Dev. 2001;15: 1783-1795.
35.
Winicov I, Perry RP.Synthesis methylation, and capping of nuclear RNA by a subcellular system. Biochemistry. 1976;15: 5039-5046.
36.
Minvielle-Sebastia L, Keller W.mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription. Curr Opin Cell Biol. 1999;11: 352-357.
37.
Reeder RH, Lang WH.Terminating transcription in eukaryotes: lessons learned from RNA polymerase I. Trends Biochem Sci. 1997;22: 473-477.
38.
Darnell JE, Philipson L, Wall R, Adesnik M.Polyadenylic acid sequences: role in conversion of nuclear RNA into messenger RNA. Science. 1971;174: 507-510.
39.
Crick F.Split genes and RNA splicing. Science. 1979; 204: 264-271.
40.
Palacios IM.RNA processing: splicing and the cytoplasmic localisation of mRNA. Curr Biol. 2002;12: R50-R52.
41.
Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, Liuni S.Structural and functional features of eukaryotic mRNA untranslated regions. Gene. 2001;276: 73-81.
42.
Adams JM, Cory S.Untranslated nucleotide sequence at the 5’-end of R17 bacteriophage RNA. Nature. 1970; 227: 570-574.
43.
Forget BG, Marotta CA, Weissman SM, Cohen-Solal M.Nucleotide sequences of the 3’-terminal untranslated region of messenger RNA for human βglobin chain. Proc Natl Acad Sci USA. 1975;72: 3614-3618.
44.
Chang JC, Temple GF, Poon R, Neumann KH, Kan YW.The nucleotide sequences of the untranslated 5’ regions of human α-and β-globin mRNAs. Proc Natl Acad Sci USA. 1977;74: 5145-5149.
45.
Veyrune JL, Hesketh J, Blanchard JM.3’ untranslated regions of c-myc and c-fos mRNAs: multifunctional elements regulating mRNA translation, degradation and subcellular localization. Prog Mol Subcell Biol. 1997;18: 35-63.
46.
Wormington M.Unmasking the role of the 3’ UTR in the cytoplasmic polyadenylation and translational regulation of maternal mRNAs. Bioessays. 1994;16: 533-535.
47.
Sonenberg N.mRNA translation: influence of the 5’ and 3’ untranslated regions. Curr Opin Genet Dev. 1994;4: 310-315.
48.
Dickey LF, Wang YH, Shull GE, Wortman IA 3rd, Theil EC.The importance of the 3’-untranslated region in the translational control of ferritin mRNA. J Biol Chem. 1988;263: 3071-3074.
49.
Mignone F, Gissi C, Liuni S, Pesole G.Untranslated regions of mRNAs. Genome Biol. 2002;3-3.
50.
Lafontaine DL, Tollervey D.The function and synthesis of ribosomes. Nat Rev Mol Cell Biol. 2001;2: 514-520.
51.
Schimmel P, Ribas de Pouplana L.Transfer RNA: from minihelix to genetic code. Cell. 1995;81: 983-986.
52.
Brown GL, Lee S.Amino-acid-transfer ribonucleic acid: structure and function. Br Med Bull. 1965;21: 236-243.
53.
Saks ME, Sampson JR, Abelson JN.The transfer RNA identity problem: a search for rules. Science. 1994;263: 191-197.
54.
Noller HF, Yusupov MM, Yusupova GZ, Baucom A, Cate JH.Translocation of tRNA during protein synthesis. FEBS Lett. 2002;514: 11-16.
55.
Moore PB.Ribosomes: protein synthesis in slow motion. Curr Biol. 1997;7: R179-R181.
56.
Wold F.In vivo chemical modification of proteins (post-translational modification). Annu Rev Biochem. 1981; 50: 783-814.
57.
Yewdell JW.Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol. 2001;11: 294-297.
58.
Han KK, Martinage A.Post-translational chemical modification(s) of proteins. Int J Biochem. 1992;24: 19-28.
59.
Saibil H.Molecular chaperones: containers and surfaces for folding, stabilising or unfolding proteins. Curr Opin Struct Biol. 2000;10: 251-258.
60.
Johnson ES, Bartel B, Seufert W, Varshavsky A.Ubiquitin as a degradation signal. EMBO J. 1992;11: 497-505.
61.
Hochstrasser M.Ubiquitin-dependent protein degradation. Annu Rev Genet. 1996;30: 405-439.
62.
Laney JD, Hochstrasser M.Substrate targeting in the ubiquitin system. Cell. 1999;97: 427-430.
Cohen JA.Chemistry and structure of nucleic acids of bacteriophages. Many forms of nucleic acids of bacteriophages show the ways that information is stored and reproduced. Science. 1967;158: 343-351.
67.
Minton NP, Oultram JD.Host: vector systems for gene cloning in Clostridium. Microbiol Sci. 1988;5: 310-315.
68.
Kim UJ, Shizuya H, Kang HL, et al.A bacterial artificial chromosome-based framework contig map of human chromosome 22q. Proc Natl Acad Sci USA. 1996;93: 6297-6301.
69.
Moir DT, Dorman TE, Smyth AP, Smith DR.A human genome YAC library in a selectable high-copy-number vector. Gene. 1993;125: 229-232.
70.
Kao FT, Hartz JA, Law ML, Davidson JN.Isolation and chromosomal localization of unique DNA sequences from a human genomic library. Proc Natl Acad Sci USA. 1982;79: 865-869.
Spoerel NA, Kafatos FC.Isolation of full-length genes: walking the chromosome. Methods Enzymol. 1987;152: 598-603.
81.
Baumforth KR, Nelson PN, Digby JE, O’Neil JD, Murray PG.Demystified... the polymerase chain reaction. Mol Pathol. 1999;52: 1-10.
82.
Eisenstein BI.The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis. N Engl J Med. 1990;322: 178-183.
83.
Erlich HA, Gelfand D, Sninsky JJ.Recent advances in the polymerase chain reaction. Science. 1991;252: 1643-1651.
84.
Aurelius E, Johansson B, Skoldenberg B, Staland A, Forsgren M.Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet. 1991;337: 189-192.
85.
Bustin SA, Dorudi S.Molecular assessment of tumour stage and disease recurrence using PCR-based assays. Mol Med Today. 1998;4: 389-396.
86.
Biondi A, Rambaldi A.Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemia. Stem Cells. 1994;12: 394-401.
87.
Raj GV, Moreno JG, Gomella LG.Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer. 1998;82: 1419-1442.
88.
Jackson JB.The polymerase chain reaction in transfusion medicine. Transfusion. 1990;30: 51-57.
89.
Westwood SA, Werrett DJ.An evaluation of the polymerase chain reaction method for forensic applications. Forensic Sci Int. 1990;45: 201-215.
90.
Decorte R, Cassiman JJ.Forensic medicine and the polymerase chain reaction technique. J Med Genet. 1993;30: 625-633.
91.
Hagelberg E, Bell LS, Allen T, Boyde A, Jones SJ, Clegg JB.Analysis of ancient bone DNA: techniques and applications. Philos Trans R Soc Lond B Biol Sci. 1991;333: 399-407.
92.
Krings M, Stone A, Schmitz RW, Krainitzki H, Stoneking M, Paabo S.Neandertal DNA sequences and the origin of modern humans. Cell. 1997;90: 19-30.
93.
Rappolee DA, Wang A, Mark D, Werb Z.Novel method for studying mRNA phenotypes in single or small numbers of cells. J Cell Biochem. 1989;39: 1-11.
94.
Becker-Andre M, Hahlbrock K.Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res. 1989;17: 9437-9446.
95.
Hamoui S, Benedetto JP, Garret M, Bonnet J.Quantitation of mRNA species by RT-PCR on total mRNA population. PCR Methods Appl. 1994;4: 160-166.
96.
Bustin SA.Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000;25: 169-193.
Heid CA, Stevens J, Livak KJ, Williams PM.Real time quantitative PCR. Genome Res. 1996;6: 986-994.
103.
Simpson DA, Feeney S, Boyle C, Stitt AW.Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR. Mol Vis. 2000;6: 178-183.
104.
Cardullo RA, Agrawal S, Flores C, Zamecnik PC, Wolf DE.Detection of nucleic acid hybridization by nonradiative fluorescence resonance energy transfer. Proc Natl Acad Sci USA. 1988;85: 8790-8794.
105.
Holland PM, Abramson RD, Watson R, Gelfand DH.Detection of specific polymerase chain reaction product by utilizing the 5’—3’ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA. 1991;88: 7276-7280.
106.
King HC, Sinha AA.Gene expression profile analysis by DNA microarrays: promise and pitfalls. JAMA. 2001;286: 2280-2288.
107.
Graham CA, Hill AJ.Introduction to DNA sequencing. Methods Mol Biol. 2001;167: 1-12.
Lilley KS, Razzaq A, Dupree P.Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation. Curr Opin Chem Biol. 2002;6: 46-50.
116.
Tefferi A, Wieben ED, Dewald GW, Whiteman DA, Bernard ME, Spelsberg TC.Primer on medical genomics part II: Background principles and methods in molecular genetics. Mayo Clin Proc. 2002;77: 785-808.
117.
Tefferi A, Bolander ME, Ansell SM, Wieben ED, Spelsberg TC.Primer on medical genomics. Part III: Microarray experiments and data analysis. Mayo Clin Proc. 2002;77: 927-940.
118.
Pardanani A, Wieben ED, Spelsberg TC, Tefferi A.Primer on medical genomics. Part IV: Expression proteomics. Mayo Clin Proc. 2002;77: 1185-1196.
119.
Elkin PL.Primer on medical genomics part V: bioinformatics. Mayo Clin Proc. 2003;78: 57-64.
120.
Ensenauer RE, Reinke SS, Ackerman MJ, Tester DJ, Whiteman DA, Tefferi A.Primer on medical genomics. Part VIII: Essentials of medical genetics for the practicing physician. Mayo Clin Proc. 2003;78: 846-857.
121.
Shaughnessy J, Jr.Primer on medical genomics. Part IX: scientific and clinical applications of DNA microarrays—multiple myeloma as a disease model. Mayo Clin Proc. 2003;78: 1098-1109.
122.
Russell SJ, Peng KW.Primer on medical genomics. Part X: Gene therapy. Mayo Clin Proc. 2003;78: 1370-1383.
123.
Spurbeck JL, Adams SA, Stupca PJ, Dewald GW.Primer on medical genomics. Part XI: Visualizing human chromosomes. Mayo Clin Proc. 2004;79: 58-75.
124.
Goetz MP, Ames MM, Weinshilboum RM.Primer on medical genomics. Part XII: Pharmacogenomics—general principles with cancer as a model. Mayo Clin Proc. 2004;79: 376-384.
125.
Hook CC, DiMagno EP, Tefferi A.Primer on medical genomics. Part XIII: Ethical and regulatory issues. Mayo Clin Proc. 2004;79: 645-650.
